These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9671101)

  • 1. 5-HT1A receptor-mediated inhibition of long-term potentiation in rat visual cortex.
    Edagawa Y; Saito H; Abe K
    Eur J Pharmacol; 1998 May; 349(2-3):221-4. PubMed ID: 9671101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin 5-HT2 receptor-phospholipase C system inhibits the induction of long-term potentiation in the rat visual cortex.
    Edagawa Y; Saito H; Abe K
    Eur J Neurosci; 2000 Apr; 12(4):1391-6. PubMed ID: 10762367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the 5-HT1A receptor selectively suppresses NMDA receptor-mediated synaptic excitation in the rat visual cortex.
    Edagawa Y; Saito H; Abe K
    Brain Res; 1999 May; 827(1-2):225-8. PubMed ID: 10320714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-OH-DPAT suppresses the induction of LTP in brain slices of the rat lateral amygdala.
    Pollandt S; Drephal C; Albrecht D
    Neuroreport; 2003 May; 14(6):895-7. PubMed ID: 12858056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin inhibits the induction of long-term potentiation in rat primary visual cortex.
    Edagawa Y; Saito H; Abe K
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Aug; 22(6):983-97. PubMed ID: 9789882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory modulation of long-term potentiation via the 5-HT1A receptor in slices of the rat hippocampal dentate gyrus.
    Sakai N; Tanaka C
    Brain Res; 1993 Jun; 613(2):326-30. PubMed ID: 8186986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding.
    Bijak M; Tokarski K; Czyrak A; Maćkowiak M; Wedzony K
    Eur J Pharmacol; 1996 Jun; 305(1-3):79-85. PubMed ID: 8813535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S; MacDonald E; Koivisto E; Stefanski R; Haapalinna A; Riekkinen P; Sirviö J
    J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors.
    Alkadhi KA; Salgado-Commissariat D; Hogan YH; Akpaudo SB
    J Physiol; 1996 Oct; 496 ( Pt 2)(Pt 2):479-89. PubMed ID: 8910231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro.
    Dupont LJ; Pype JL; Demedts MG; De Leyn P; Deneffe G; Verleden GM
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1479-86. PubMed ID: 9817696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.